Healthcare ❯ Pharmaceuticals ❯ Drug Pricing

Medicaid

Direct-to-Consumer Sales Pfizer Patient Access Prescription Drugs Federal Regulations Consumer Access Lower-Income Americans Cost Reduction Health Equity Healthcare Sector Performance Most Favored Nation Pricing Consumer Impact Government Negotiations

Pfizer–Trump Drug-Pricing Deal and ‘TrumpRx’ Plan Jolt Health-Care Stocks Higher

The agreement links Medicaid price cuts to a three-year tariff reprieve for Pfizer, signaling clearer policy direction.